| GUIDELINES |
|
| Year : 2014 | Volume
: 9
| Issue : 5 | Page : 113-120 |
|
|
Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension in children
Maha Al Dabbagh1, Hanna Banjar2, Nasser Galal3, Amjad Kouatli3, Hammam Kandil3, May Chehab4
1 Department of Pediatric, King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia
2 Department of Pediatric, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
3 Department of Pediatric Cardiology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia
4 Pediatric Intensive Care, Prince Sultan Medical Military City, Riyadh, Saudi Arabia
Correspondence Address:
Maha Al Dabbagh
MD, Head, Pulmonary Section, Department of Pediatric, King Fahd Armed Forces Hospital, Head, Pediatric Taskforce, Saudi Association for Pulmonary Hypertension, PO Box 9862, Jeddah 21159
Saudi Arabia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1817-1737.134053
|
|
|
Pulmonary hypertension (PH) is relatively uncommon in children. Pulmonary arterial hypertension (PAH) in pediatric comprises a wide spectrum of diseases, from a transient neonatal condition to a progressive disease associated with morbidity and mortality. Most common PAH in pediatric are idiopathic (IPAH) or PAH associated with congenital heart disease (PAH-CHD), while other associated conditions, such as connective tissue disease (CTD), are less common in pediatrics. Despite better understanding of PH and the availability of new medications during recent decades; the diagnosis, investigation and choice of therapy remain a challenge in children, as evidence-based recommendations depend mainly on adult studies.
In this review, we provide a detailed discussion about the distinctive features of PAH in pediatric, mainly emphacysing on classification and diagnostic algorithm. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
